Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.

MLA

Chenjing Sun, et al. “Neuroimaging and Clinicopathological Differences between Tumefactive Demyelinating Lesions and Sentinel Lesions of Primary Central Nervous System Lymphoma.” Frontiers in Immunology, vol. 13, Aug. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fimmu.2022.986473.

APA

Chenjing Sun, Jinming Han, Ye Lin, Xiaokun Qi, Changqing Li, Jianguo Liu, & Feng Qiu. (2022). Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma. Frontiers in Immunology, 13, 1–9. https://doi.org/10.3389/fimmu.2022.986473

Chicago

Chenjing Sun, Jinming Han, Ye Lin, Xiaokun Qi, Changqing Li, Jianguo Liu, and Feng Qiu. 2022. “Neuroimaging and Clinicopathological Differences between Tumefactive Demyelinating Lesions and Sentinel Lesions of Primary Central Nervous System Lymphoma.” Frontiers in Immunology 13 (August): 1–9. doi:10.3389/fimmu.2022.986473.